Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
adalimumab (humira) (1 trial)
vitamin d3 (1 trial)
Arthritis (Phase 4)
Cardiovascular Diseases (Phase 4)
Joint Diseases (Phase 4)
Lupus Erythematosus, Systemic (Phase 1)
Trials (2 total)
Trial APIs (2 total)